布地奈德缓释胶囊有哪几种版本

Introduction: As a glucocorticoid drug, budesonide sustained-release capsules have multiple versions on the market, including the original German version, the Turkish version exported from Germany, and the Italian version. Different versions have slight differences in specifications and prices, but they have all won the trust of patients with their significant efficacy and safety. However, when using budesonide sustained-release capsules, patients need to pay special attention to possible side effects such as changes in adrenocortical function, discontinuation symptoms, increased risk of infection, and interactions with other drugs.

Overview of versions of budesonide sustained-release capsules

As an important therapeutic drug, budesonide sustained-release capsules have multiple versions on the market to meet the needs of different patients. The following are some of the more common versions and their brief introductions:

German version: This version is produced by a well-known German pharmaceutical company, with a specification of 3mg*100 capsules and a price of about 1,500$.

The German Dr. Falk Pharma GmbH produces and exports the Turkish version: also produced by the German Dr. Falk Pharma GmbH, but the version is specially customized for the Turkish market. The specification is 3mg*100 capsules and costs about 940$.

The Italian version of budesonide sustained-release capsules: The Italian version of budesonide sustained-release capsules is 3mg*50 capsules per box, and the price is about 980$.

Precautions for budesonide sustained-release capsules

When using budesonide sustained-release capsules, patients need to pay special attention to the following aspects to ensure medication safety and maximize efficacy:

Hyperadrenocortical hyperfunction and adrenal axis suppression: As a glucocorticoid, long-term use of budesonide may lead to hyperadrenocortical function and even inhibit the normal function of the adrenal axis. Patients should regularly monitor relevant indicators and adjust the dosage under the guidance of a doctor.

Steroid withdrawal symptoms: When switching from other systemic corticosteroids to budesonide extended-release capsules, patients may experience withdrawal symptoms, such as fatigue, joint pain, etc. To avoid such a situation, the dosage should be gradually reduced and discontinued under the guidance of a doctor.

Increased risk of infection: Budesonide can suppress immune system function, making patients more susceptible to infections. Patients should pay attention to personal hygiene during medication, avoid contact with sources of infection, and pay close attention to their own health.

Other corticosteroid effects: Budesonide may also cause a series of corticosteroid side effects, such as headache, nausea, vomiting, stomach pain, diarrhea and constipation. If symptoms are severe or persist, seek medical treatment promptly and inform your doctor.

Avoid taking it with alcohol: Alcohol may increase the risk of gastrointestinal bleeding and affect the efficacy of the drug. Avoid drinking alcohol while taking budesonide extended-release capsules.